Top 7 Benefits and Important Considerations When Using Egilok

When using Egilok, patients should be aware of possible side effects. Here are some common side effects users may experience:

• Nervous system: Fatigue, headaches, dizziness, tingling, muscle cramps, drowsiness, insomnia, depression, attention disorders, nightmares, anxiety, agitation, sexual dysfunction, memory problems, confusion, hallucinations.
• Cardiovascular system: Slow heart rate, cold hands and feet, palpitations, postural hypotension, worsening heart failure symptoms, swelling, chest pain, first-degree AV block, arrhythmia, conduction disorders, gangrene in cases of peripheral vascular disease.
• Gastrointestinal system: Nausea, diarrhea, abdominal pain, constipation, vomiting, dry mouth, liver function test changes.
• Skin: Skin rashes (psoriasis, hives, and lesions from dystrophy), hair loss, excessive sweating, worsened psoriasis, increased sensitivity to light.
• Respiratory system: Shortness of breath on exertion, bronchospasm even without COPD, rhinitis.
• Sensory system: Vision disturbances, dry eyes, eye irritation, conjunctivitis, tinnitus, taste disorders.
• Metabolism: Weight gain.
• Hematologic system: Reduced platelet count.
• Musculoskeletal system: Joint pain.
• Lab results: Slight increase in serum triglycerides.

If any of the above side effects occur and cause discomfort, patients should immediately inform their doctor. The doctor will provide specific instructions for managing these effects and may adjust the dosage or discontinue the use of Egilok if necessary. In cases of severe or unexplained side effects, stopping Egilok may be required.

If a patient misses a dose or overdoses on Egilok, the following actions should be taken:

Overdose:

• Provide intensive care, monitoring the patient's circulation, respiration, blood glucose levels, kidney function, and electrolyte balance.
• If the product was recently taken, reduce absorption by inducing vomiting or performing gastric lavage, followed by activated charcoal.
• Administer β1 agonists intravenously every 2-5 minutes, or provide IV fluids if needed.
• If β1 agonists are unavailable, intravenous atropine/dopamine, dobutamine, or norepinephrine can be used.
• Consider using Glucagon to reverse the effects of strong beta-blockade.
• For emergencies, consider pacemaker placement or β2 agonists (such as terbutaline) for bronchospasm.

Missed Dose:

• If a dose is missed, take it as soon as remembered.
• If it's close to the next scheduled dose, skip the missed dose and continue as normal.

Always follow your doctor or pharmacist's instructions to avoid both overdosing or missing doses. If any issues arise or concerning symptoms occur, seek immediate medical assistance.

Product Interactions: It is important to note that Egilok lowers blood pressure, and combining it with other antihypertensive drugs may increase the risk of low blood pressure. Below is a list of medications that should be used with caution alongside Egilok:

• Antiarrhythmic oral medications (quinidine and amiodarone) and parasympathomimetic agents: These can increase the risk of bradycardia, low blood pressure, and atrioventricular block.
• Digitalis glycosides: These can increase the risk of bradycardia and conduction disorders.
• Other antihypertensive drugs like reserpine, guanethidine, alpha-methyldopa, clonidine, and guanfacine: These can increase the risk of bradycardia and low blood pressure.
• Clonidine: When discontinuing the medication, Metoprolol should be stopped before clonidine to prevent hypertensive rebound.
• CNS depressants like sedatives, hypnotics, alcohol, and tricyclic antidepressants: These can increase the risk of low blood pressure.
• Sleep-inducing agents with addictive potential: These can increase the risk of heart suppression.
• Ergotamine: This can enhance vasoconstriction.
• NSAIDs like indomethacin: These may reduce the antihypertensive effects of Egilok.
• Estrogens: These can reduce the antihypertensive effects of Metoprolol.
• Oral antidiabetic medications and insulin: Metoprolol may enhance the hypoglycemic effect.
• Enzyme inhibitors like alcohol, cimetidine, SSRIs (e.g., paroxetine, fluoxetine, sertraline): These can increase Metoprolol's effects due to higher plasma concentrations.
• Enzyme inducers like rifampicin, barbiturates: These can reduce Metoprolol's effects by increasing hepatic metabolism.

Storage Instructions: To ensure the effectiveness of Egilok, proper storage is crucial. Follow these guidelines:

• Store Egilok at room temperature in a cool, dry place, away from heat and moisture.
• Keep the product away from direct sunlight or intense light.
• Store the medication in a high, secure place, out of reach of children, to prevent accidental ingestion.

Patients should always follow their doctor's instructions and inform them of all other medications being taken to avoid harmful interactions. If there are any concerns or symptoms, consult a doctor or pharmacist for guidance.

To ensure the safe and effective use of Egilok, keep in mind the following precautions before starting treatment:

• Allergy and interaction information: Before using Egilok, inform your doctor about any allergies or reactions to medications, foods, or substances to avoid adverse drug interactions.
• Other medications: Let your doctor know if you are taking any other prescription drugs, supplements, or herbal remedies to prevent potential negative interactions with Egilok.
• Surgery, pregnancy, and breastfeeding: If you are undergoing surgery, pregnant, or breastfeeding, consult your doctor about using Egilok to receive tailored guidance.
• Special care when discontinuing the medication: Patients with coronary artery disease should be closely monitored when stopping Egilok to avoid complications.
• Avoid use in patients with respiratory obstruction: Egilok should not be used in patients with respiratory conditions to prevent adverse effects.
• Adjustment for diabetes patients: Diabetes patients may need to adjust their diabetic treatment dosage when taking Egilok.
• Alpha blocker use in pheochromocytoma patients: Pheochromocytoma patients should combine Egilok with an alpha blocker as per their doctor's guidance.

Remember to follow these guidelines and always consult your doctor or pharmacist if you have any questions.

Indications: Egilok is prescribed for conditions such as hypertension, angina, post-myocardial infarction recovery, arrhythmias, hyperthyroidism, and migraine prevention. However, it is crucial to be aware of situations where this medication is contraindicated.

Contraindications:

• Egilok should not be used in patients who are hypersensitive to any of its components or other beta-blockers. It is also contraindicated in cases such as second or third-degree atrioventricular block, severe sinus bradycardia, sick sinus syndrome, cardiogenic shock, decompensated heart failure, and peripheral arterial circulation disorders.
• Egilok should not be used in acute myocardial infarction if the heart rate is below 45 beats per minute, the PQ interval exceeds 240ms, systolic blood pressure is under 100mmHg, or in cases requiring ongoing or staged treatment with a drug affecting myocardial contractility (beta-agonists).

Therefore, before starting Egilok, patients must consult with their doctor to ensure there are no contraindications and that the medication is used safely and effectively.

How to use:

• Egilok is taken orally, either before or after meals, with no significant effect on absorption.
• If necessary, the pill can be split to make swallowing easier.

Recommended Dosage: The dosage of Egilok should be adjusted to each individual case to avoid excessive slowing of the heart rate. Below are typical dosages for common conditions:

• Hypertension: Start with 25-50mg, twice daily. It can be increased to 100mg, twice daily, or combined with other antihypertensive medications.
• Angina: Initial dose is 25-50mg, 2-3 times daily, with potential increase to 200mg/day or combined with other medications.
• Post-myocardial infarction maintenance: 50-100mg, twice daily.
• Arrhythmia: Start with 25-50mg, 2-3 times daily, with potential increase to 200mg/day or combined with other medications.
• Hyperthyroidism: Daily dosage of 150-200mg, divided into 3-4 doses.
• Prevention of migraines: 50mg, twice daily.
• Dosage for special patient groups:
  • Renal patients: No adjustment needed.
  • Hepatic cirrhosis patients: No adjustment needed.
  • Severe hepatic impairment: Dose reduction may be required.
  • Older adults: No adjustment needed.
  • Children: Due to limited research, consultation with a physician is necessary before use.

Remember, always follow the prescribed dosage and instructions from your doctor or pharmacist to ensure safe and effective use of Egilok.